Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 18/20 | 0.68 |
| ▸ | CTSS | P25774 | 3/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1350139 | 1.00 | CTSK (0.68) | CTSKCTSSMEN1GAAKMT2A | |
| SCHEMBL345582 | 1.00 | CTSK (0.68) | CTSKCTSSMEN1GAAKMT2A | |
| Hydrochloric Acid SCHEMBL6037571 | 0.98 | CTSK (0.66) | CTSKCTSSMEN1GAAKMT2A | |
| SCHEMBL14820490 | 0.95 | CTSK (0.62) | CTSKCTSSMEN1GAAKMT2A | |
| SCHEMBL18875931 | 0.95 | CTSK (0.62) | CTSKCTSSMEN1GAAKMT2A | |
| SCHEMBL3233192 | 0.95 | CTSK (0.62) | CTSKCTSSMEN1GAAKMT2A | |
| SCHEMBL29826317 | 0.94 | CTSK (0.69) | CTSKCTSS | |
| SCHEMBL7555645 | 0.94 | CTSK (0.60) | CTSKCTSS | |
| SCHEMBL5050858 | 0.94 | CTSK (0.60) | CTSKCTSS | |
| SCHEMBL7555646 | 0.94 | CTSK (0.60) | CTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118955391-A | Substituted N- (2-oxo ethyl) benzamide derivative and preparation method and application thereof | 中国医学科学院医药生物技术研究所 | 2024-11-15 | — | — | CN | disclosed |
| WO-2024163962-A1 | 3-((1,1-DIOXIDO-2,3,4,5-TETRAHYDROBENZO[F][1,2,5]THIADIAZEPIN-8-YL)OXY)-2-FLUOROACRYLIC ACID DERIVATIVES AS SODIUM TAUROCHOLATE CO-TRANSPORTING POLYPEPTIDE (NTCP) INHIBITORS FOR THE TREATMENT OF CHOLESTASIS | Hemoshear Therapeutics, Inc. (US) | 2024-08-08 | — | — | WO | disclosed |
| US-20240226343-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. | 2024-07-11 | — | — | US | disclosed |
| US-11932628-B2 | Selective small molecule peptidomimetic melanocortin ligands | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2024-03-19 | — | — | US | disclosed |
| US-20230398226-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2023-12-14 | — | — | US | disclosed |
| US-11833213-B2 | Compositions and methods for the treatment of viral infections | CIDARA THERAPEUTICS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| US-20220213068-A1 | SELECTIVE SMALL MOLECULE PEPTIDOMIMETIC MELANOCORTIN LIGANDS | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2022-07-07 | — | — | US | disclosed |
| US-20220177471-A1 | N-1 BRANCHED ALKYL SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS, COMPOSITIONS, AND METHODS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2022-06-09 | — | — | US | disclosed |
| EP-3980415-A1 | N-1 BRANCHED ALKYL SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS, COMPOSITIONS, AND METHODS | 3M Innovative Properties Company (US) | 2022-04-13 | — | — | EP | disclosed |
| CN-113924297-A | N-1 branched alkyl substituted imidazo [4,5-c ] quinoline compounds, compositions, and methods | 3M创新有限公司 | 2022-01-11 | — | — | CN | disclosed |
| EP-1695961-A1 | UREA DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE | Takeda Pharmaceutical Company Limited (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-6242494-B1 | ANGIOGENESIS INHIBITORS, ANTITUMOR AGENTS, DIABETIC RETINOPATHY, AND ANTIINFLAMMATORY AGENTS | ABBOTT LABORATORIES | 2001-06-05 | — | — | US | disclosed |
| EP-1073633-A2 | SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 | ABBOTT LABORATORIES (US) | 2001-02-07 | — | — | EP | disclosed |
| WO-1999057098-A2 | SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 | ABBOTT LABORATORIES (US) | 1999-11-11 | — | — | WO | disclosed |
| EP-0136720-B1 | ENKEPHALIN ANALOGS | G.D. Searle & Co. (US) | 1989-09-20 | — | — | EP | disclosed |
| US-4603121-A | ANALGESICS | G. D. SEARLE & CO. (US) | 1986-07-29 | — | — | US | disclosed |
| EP-0136720-A2 | Enkephalin analogs | G.D. Searle & Co. (US) | 1985-04-10 | — | — | EP | disclosed |
| EP-0033504-B1 | PENTAPEPTIDES OF THE ENCEPHALINE TYPE, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE | Richter Gedeon Vegyészeti Gyár R.T. (HU) | 1984-10-24 | — | — | EP | disclosed |
| US-4339440-A | HYPOTENSIVES | RICHTER GEDEON VEGYESZETI GYAR RT (HU) | 1982-07-13 | — | — | US | disclosed |
| EP-0033504-A2 | Pentapeptides of the encephaline type, process for their preparation and medicaments containing these | Richter Gedeon Vegyészeti Gyár R.T. (HU) | 1981-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230398226-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | FCGR3B, ALB, FCGR1A | CTSK 315/4885CTSS 116/4885MEN1 3968/4885 |
| US-11932628-B2 | Selective small molecule peptidomimetic melanocortin ligands | MC1R, MC3R, MC4R | CTSK 2752/4885CTSS 3135/4885MEN1 137/4885 |
| US-11833213-B2 | Compositions and methods for the treatment of viral infections | FCGR3B, ALB, FCGR1A | CTSK 315/4885CTSS 116/4885MEN1 3968/4885 |
| US-20220213068-A1 | SELECTIVE SMALL MOLECULE PEPTIDOMIMETIC MELANOCORTIN LIGANDS | MC1R, MC3R, MC4R | CTSK 2752/4885CTSS 3135/4885MEN1 137/4885 |
| US-20220177471-A1 | N-1 BRANCHED ALKYL SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS, COMPOSITIONS, AND METHODS | IFNG, IFNAR1, IRF3 | CTSK 3049/4885CTSS 2581/4885MEN1 1110/4885 |
| US-20240226343-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | NPY1R, NPY2R, NPY4R | CTSK 798/4885CTSS 1279/4885MEN1 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.